Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Stock analysts at Barrington Research increased their Q3 2023 earnings per share estimates for shares of Henry Schein in a research report issued to clients and investors on Tuesday, August 8th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $1.32 per share for the quarter, up from their prior estimate of $1.31. Barrington Research has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $5.26 per share. Barrington Research also issued estimates for Henry Schein’s Q4 2023 earnings at $1.44 EPS, FY2023 earnings at $5.29 EPS, Q1 2024 earnings at $1.26 EPS and FY2024 earnings at $5.69 EPS.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its earnings results on Monday, August 7th. The company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.28 by $0.03. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.13 billion. Henry Schein had a net margin of 3.64% and a return on equity of 15.76%. The business’s quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.16 earnings per share.
Check Out Our Latest Report on Henry Schein
Henry Schein Price Performance
NASDAQ HSIC opened at $77.42 on Thursday. The stock has a market capitalization of $10.14 billion, a P/E ratio of 22.77, a P/E/G ratio of 2.13 and a beta of 0.83. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.94 and a current ratio of 1.72. The business’s fifty day moving average is $78.43 and its two-hundred day moving average is $80.05. Henry Schein has a 1 year low of $64.75 and a 1 year high of $89.72.
Insider Buying and Selling at Henry Schein
In other Henry Schein news, EVP Mark E. Mlotek sold 24,747 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $76.68, for a total value of $1,897,599.96. Following the transaction, the executive vice president now owns 69,138 shares in the company, valued at approximately $5,301,501.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CEO David B. Brous, Jr. sold 11,157 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $74.86, for a total value of $835,213.02. Following the completion of the sale, the chief executive officer now owns 68,690 shares of the company’s stock, valued at approximately $5,142,133.40. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Mark E. Mlotek sold 24,747 shares of the firm’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $76.68, for a total transaction of $1,897,599.96. Following the transaction, the executive vice president now directly owns 69,138 shares in the company, valued at approximately $5,301,501.84. The disclosure for this sale can be found here. Insiders have sold a total of 75,019 shares of company stock valued at $5,651,018 in the last 90 days. 1.14% of the stock is currently owned by corporate insiders.
Institutional Trading of Henry Schein
Several large investors have recently added to or reduced their stakes in HSIC. Cambridge Investment Research Advisors Inc. boosted its holdings in Henry Schein by 2.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after purchasing an additional 122 shares in the last quarter. HB Wealth Management LLC increased its holdings in shares of Henry Schein by 0.8% during the 1st quarter. HB Wealth Management LLC now owns 15,822 shares of the company’s stock valued at $1,290,000 after acquiring an additional 123 shares during the last quarter. ETF Managers Group LLC increased its holdings in shares of Henry Schein by 1.5% during the 1st quarter. ETF Managers Group LLC now owns 8,278 shares of the company’s stock valued at $675,000 after acquiring an additional 123 shares during the last quarter. Summit Trail Advisors LLC lifted its holdings in Henry Schein by 2.1% in the 4th quarter. Summit Trail Advisors LLC now owns 6,323 shares of the company’s stock worth $505,000 after purchasing an additional 132 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its position in Henry Schein by 2.7% during the second quarter. Sequoia Financial Advisors LLC now owns 5,116 shares of the company’s stock worth $415,000 after purchasing an additional 133 shares during the period. 94.75% of the stock is owned by institutional investors.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Profitably Trade Stocks at 52-Week Highs
- 3 Best Renewable Energy Stocks as Summer Heat Builds
- Consumer Discretionary Stocks Explained
- Kinder Morgan Shines With Dividend Yield, Cash Flow, Buybacks
- How to Invest in Apparel Stocks
- 3 Stocks to Buy No Matter Which Way Inflation Moves
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
